AKYA: Rega marang dodolan Akoya Biosciences Inc
The potential of Akoya Biosciences (AKYA) relies on the expansion of its instrument network and the recognition of its tissue analysis methods in oncology. Examining the current P/S multiple on GURU.Markets, we see that the parameter reaches 0.80. However, high costs and the slow adoption of innovations in clinics constrain growth, while the geopolitical stability of biomedicine minimizes external threats to the business.
Rincian analitis perusahaan Akoya Biosciences (AKYA)
Investors use this ratio to determine whether an asset is overbought relative to its actual sales by assessing the market value of one dollar of revenue. Analyzing the market capitalization-to-revenue ratio reveals that the high valuation of Akoya Biosciences (AKYA) is supported by the retention of unique bioanalysis specialists and software integrators, which minimizes the business's technological risks.
